The landscape of dementia prognosis has developed significantly with the arrival of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of indications emerge. Although these technological advancements stand for exceptional development in being familiar